share_log
Breakings ·  Nov 6 21:29
Teva Pharm CEO Francis Says on Track to Meet Growth Targets by 2027 of Revenue Growth, Operating Margin and Net Debt/Ebitda
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment